Friday, June 03, 2022 2:07:43 PM
Well anyway, low and behold it was listed at $23.++ cents a share! it is similar to our RGBP, who seems to be struggling right now, so come to the realization that Pharmas never are overnight successes! I can't say for sure, but RGBP seems to have more going for it than NASD ever had, if my interpretation is correct?
So sell if you have to, but this Investment area is full of potential! While rgbp appears to be sleeping at the wheel at times, one of the last steps toward commercialization have already been achieved, with maybe Two left, one of which is is in the clinical trials stage as we speak, heading toward completion! Then, mRNA vaccines and Therapies are in the fast track of testing and completion, due to its chemistry I suppose, so instead of 5 years, sometimes longer for a Vaccine to be approved, it may only require 1 or 2 years total testing time! We are on our way, though, and once concluded, the Cancer(s) vaccine should be a public success? So, this genre usually takes the longest time before it hits the public! GLTA.....
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM